Business Context and Reporting Period
Company: Northrop Grumman Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 19, 2020
Purpose: To supplement risk factors in the Annual Report on Form 10-K for the fiscal year ended December 31, 2019, specifically addressing the global outbreak of coronavirus disease 2019 (COVID-19).
Key Financial Metrics
This filing is a qualitative risk disclosure and does not contain specific financial data. The text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the current period.
Material Changes and Risks
The filing identifies the following material risks associated with the COVID-19 pandemic:
- Market Volatility: Disruption in global capital markets may increase the cost of capital and adversely impact access to capital.
- Operational Disruption: Potential inability of significant portions of the workforce to work effectively due to illness, quarantines, government actions, or facility closures.
- Contract Performance: Risk of being unable to fully perform on contracts, potentially leading to increased costs that may not be fully recoverable or covered by insurance.
- Supply Chain and Customers: Possible disruption in the supply chain and delays or limitations in the ability of the U.S. Government and other customers to perform, including making timely payments.
- Investment Performance: Potential negative impact on investment performance.
Management Commentary and Outlook
Management states it is working with stakeholders (customers, employees, suppliers, and local communities) to address the pandemic responsibly. The company is monitoring the situation to assess implications for its business, supply chain, and customers, and is taking actions to mitigate adverse consequences. However, management explicitly states it cannot predict the impact of the pandemic at this time, though it could have a material adverse effect on the business, financial position, results of operations, and cash flows.
Key Facts for Investor Verification
- Verify the extent of workforce disruptions and facility closures as the pandemic evolves.
- Monitor the company's ability to recover increased costs from contracts and insurance.
- Track the timeliness of payments from the U.S. Government and other major customers.
- Assess the stability of the global supply chain for critical components.
- Review future filings for updates on the financial impact of capital market volatility.